This was the stock's third consecutive day of losses.

Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that it is ...

Perrigo is switching up leadership positions as part of its new strategic organization plan.

Perrigo Company plc PRGO is scheduled to report third-quarter 2024 earnings on Nov. 6, before the opening bell. In the last reported quarter, the company posted an earnings surprise of 10.42%. The ...

Perrigo reported revenues of $4.37 billion, down 6.1% year over year. Net sales also fell 4.5% organically. The company reported adjusted earnings of $2.57 per share for 2024, down 0.4% year over ...

Perrigo Company PLC “Almost all good businesses engage in ‘pain today’, ‘gain tomorrow’ activities”-Charlie Munger Perrigo Company plc, commonly known as Perrigo, is an American-Irish ...

Perrigo Co Plc said on Monday that the U.S. Food and Drug Administration has scheduled a meeting of external experts on Nov. 18 to review the application of its daily birth control pill for over ...

Perrigo recently made a number of acquisitions to bolster its branded portfolio, including HRA Pharma (2022; $1.9 billion) and Dr. Fresh (2020; $113 million).

Perrigo (PRGO) reported $1.08 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 8.4%. EPS of $0.29 for the same period compares to $0.45 a year ago.

Perrigo filed its own Sherman Act claim against AbbVie in 2020 in New Jersey federal court. AbbVie moved for judgment, arguing that the 2011 settlement had released any claim arising before the ...